Advertisement
U.S. markets closed

Neuren Pharmaceuticals Limited (NEU.AX)

ASX - ASX Delayed Price. Currency in AUD
20.39-0.11 (-0.54%)
As of 01:50PM AEDT. Market open.
Currency in AUD
Earnings EstimateCurrent Qtr. (Dec 2023)Next Qtr. (Mar 2024)Current Year (2024)Next Year (2025)
No. of Analysts0055
Avg. Estimate000.730.75
Low Estimate000.510.32
High Estimate001.130.96
Year Ago EPSN/AN/A1.20.73
Revenue EstimateCurrent Qtr. (Dec 2023)Next Qtr. (Mar 2024)Current Year (2024)Next Year (2025)
No. of Analysts5055
Avg. Estimate153.74MN/A153.74M173.5M
Low Estimate115.4MN/A115.4M118.72M
High Estimate191.7MN/A191.7M251.7M
Year Ago Sales231.93MN/A231.93M153.74M
Sales Growth (year/est)-33.70%N/A-33.70%12.90%
Earnings HistoryInvalid DateInvalid DateInvalid DateInvalid Date
EPS Est.N/AN/AN/AN/A
EPS ActualN/AN/AN/AN/A
DifferenceN/AN/AN/AN/A
Surprise %N/AN/AN/AN/A
EPS TrendCurrent Qtr. (Dec 2023)Next Qtr. (Mar 2024)Current Year (2024)Next Year (2025)
Current Estimate000.730.75
7 Days Ago000.730.75
30 Days Ago000.550.9
60 Days Ago000.550.91
90 Days Ago000.620.96
EPS RevisionsCurrent Qtr. (Dec 2023)Next Qtr. (Mar 2024)Current Year (2024)Next Year (2025)
Up Last 7 DaysN/AN/A1N/A
Up Last 30 DaysN/AN/A42
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesNEU.AXIndustrySector(s)S&P 500
Current Qtr.N/AN/AN/AN/A
Next Qtr.N/AN/AN/AN/A
Current Year-39.20%N/AN/AN/A
Next Year2.70%N/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A